✦ LIBER ✦

Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C

✍ Scribed by John B Wong; Gary L Davis; John G McHutchison; Michael P Manns; Janice K Albrecht

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2b plus ribavirin com

✍ Michael P Manns; John G McHutchison; Stuart C Gordon; Vinod K Rustgi; Mitchell S 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 110 KB

Evaluating rapid virological response re

✍ J.B. Wong; W.M. Rosenberg; M.P. Manns; G.L. Davis; J.G. McHutchison; J.K. Albrec 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Cost-effectiveness of peginterferon alph

✍ Uwe Siebert; Gaby Sroczynski; Siegbert Rossol; Juergen Wasem; Ulrike Ravens-Sieb 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 223 KB

PGI5 THE COST-EFFECTIVENESS OF PEGINTERF

✍ MC Fonseca; GTB Araujo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PIN8 COST-EFFECTIVENESS ANALYSIS OF PEGI

✍ VV Omelyanovsky; MV Avksentieva; I Krysanov; O Ivakhnenko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Peginterferon alfa-2b plus weight-based

✍ A. Craxi; S. Koutsounas; P. Ogurtsov; L. Chemello; M. Maticic; J. Torras; M. Dia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB